Quad Investment Management

Funding rounds backed by Quad Investment Management.

Export CSV
Funding disclosed in full
$14M
Median round
$14M
Rounds in calculation
1
Funding rounds with company descriptions, amounts, stages and announcement dates
CompanyRoundMarketInvestorsAnnouncedDetails
KaliVir Immunotherapeutics

Develops oncolytic immunotherapies for patients with advanced solid tumors

$14MSeries ABiotechUnited States
5 participantsCompany K PartnersFlexus PartnersNextransQuad Investment ManagementSV Investment